Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients

Pediatric Nephrology

Volumn 22, Issue 9, 2007, Pages 1395-

  Dharnidharka, Vikas R ^a   Wesson, Stanton K ^a   Fennell, Robert S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; SEVELAMER;

CASE REPORT; DISEASE ASSOCIATION; DRUG USE; HUMAN; KIDNEY FAILURE; LETTER; MAGNETIC RESONANCE ANGIOGRAPHY; METABOLIC ACIDOSIS; NEPHROGENIC FIBROSING DERMOPATHY; PRIORITY JOURNAL; RISK FACTOR; SKIN BIOPSY;

CHILD; CONTRAST MEDIA; FIBROSIS; GADOLINIUM; HUMANS; KIDNEY DISEASES; SKIN; SKIN DISEASES;

EID: 34447337991     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0384-z     Document Type: Letter

References (3)

1. Jain SM, Wesson S, Hassanein A, Canova E, Hoy M, Fennell RS, Dharnidharka VR (2004) Nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 19:467-470
2. Grobner T (2006) Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104-1108
3. Marco MP, Muray S, Betriu A, Craver L, Belart M, Fernandez E (2002) Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients. Nephron 92:499-500